Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study
scientific article published on 30 July 2015
Author/s
author: Hagop Kantarjian, Jorge Eduardo Cortes, Farhad Ravandi, Elias Jabbour, Gianluca Gaidano, Johan Maertens, Stephen A. Strickland, Gail J Roboz, Hamid Sayar, Jeffrey E Lancet, Norbert Vey, Gary J Schiller, Harry P Erba, Arnaud Pigneux, Heinz-August Horst, Christian Récher, Virginia M Klimek, Olatoyosi Odenike, Bayard L Powell, Angelo Michele Carella, Gary Acton, Lloyd E Damon, Michael Heuser
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.